Keefe Bruyette raises 1st Source stock price target on earnings beat
Source: Investing.com

Keefe, Bruyette & Woods raised its 1st Source price target to $92 from $82 while maintaining a Market Perform rating, citing third-quarter operating EPS of $2.09 above expectations and raising its 2027 and 2028 earnings estimates by 3% and 4%, respectively. Loan growth was 7% on a linked-quarter annualized basis, led by commercial and industrial loans at 14%; the stock was up 42% year-to-date, though InvestingPro analysis said it was trading above fair value. Separately, DA Davidson and Piper Sandler also raised price targets following recent results.
Analysis
The market mechanism is less the target-price revision than whether stronger pre-provision revenue can persist without relying on a lower credit-loss charge. A reduction in nonperforming loans can support near-term earnings, but if loan growth—especially in specialty finance and C&I—outpaces underwriting quality, today’s lower provision may reverse into higher losses with a lag. The modest CRE growth is a relative cushion, not proof that broader credit risk is benign.
After a 42% year-to-date rise, analyst target increases may offer limited incremental support unless estimates continue moving higher. The reported above-fair-value assessment is a caution, not a standalone valuation signal; the key question is whether future PPNR and net interest income can justify the rerating. The article also mixes operating and reported EPS references across updates; verify periods and definitions before using them in an earnings model.
Near term, estimate revisions can sustain sentiment, but over 1–3 months the trade depends on deposit costs, net interest margin, fee income, and credit quality—not target prices. Over 6–18 months, sustained loan growth with stable charge-offs would validate the franchise outlook; deteriorating specialty-finance performance or renewed CRE stress would challenge it. No clear read-through to PIPR’s own fundamentals follows from its analyst action on SRCE.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.38
Ticker Sentiment
Key Decisions for Investors
- Do not chase SRCE solely on the analyst revisions after the strong year-to-date advance. For an existing position, consider trimming into strength rather than treating higher targets as a fresh fundamental catalyst.
- Watch the next earnings release for sequential PPNR ex-provision trends, deposit-cost/NIM direction, net charge-offs, nonperforming loans, and specialty-finance delinquency performance. Reassess a constructive view if revenue momentum persists while credit metrics remain stable.
- Falsify the constructive thesis if guidance or estimates turn down, PPNR weakens materially, or nonperforming loans and charge-offs rise; those would indicate the lower provision is not a durable earnings tailwind.
- Before updating estimates, reconcile operating versus reported EPS and the different periods cited in the article. Without comparable definitions and current pricing/valuation work, there is insufficient basis for a precise target or a paired trade.
More News
- Guggenheim initiates Nutanix stock with buy rating on VMware opportunity
- Piper Sandler raises Coca-Cola stock price target on innovation
- From Wall Street to Silicon Valley, Anthropic IPO poised to have massive 'trickle-down effect'
- Anthropic’s IPO filing shows explosive growth, risks and staggering costs
- Microsoft offers buyouts to nearly 30% of workforce in ongoing AI shift
- Elon Musk warns more than 200 AI cloud companies face ‘guppy-level death’ as the AI boom runs into a debt crisis